OR WAIT null SECS
August 02, 2018
Modular manufacturing systems offer a less costly way to increase capacity while reducing time-to-market.
Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.
August 01, 2018
CMOs have been active over the past year in expanding their biologics production and capabilities.
Why shouldn’t biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?
July 19, 2018
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
July 18, 2018
Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency.
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
The media, by Tosoh Bioscience, is composed of calcium and phosphate buffers and offers mixed-mode properties for biomolecule purification.
July 17, 2018
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
July 12, 2018
The agency is releasing six new draft guidances to provide a regulatory framework for handling gene therapies.